Mendelsohn to Step Down, Change Role
Network - Spring 2011
John Mendelsohn, M.D., president of
MD Anderson through an incredibly productive period of nearly 15 years, recently announced plans to relinquish his leadership position when a new president is recruited and in place.
He will remain on the MD Anderson faculty, returning to clinical and translational research as co-director of its new Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.
“I’ve had the best job imaginable,” Mendelsohn says. “So much has been accomplished, but more remains to be done. I’m confident
MD Anderson will maintain its lead in translational and clinical research as well as continuing to be the nation’s number one hospital for cancer patients.”
Mendelsohn is only the third full-time president of MD Anderson in a history that spans 70 years. R. Lee Clark, M.D., served as president from 1946 to1978, and was followed by Charles A. LeMaistre, M.D., who was president from 1978 to1996, when Mendelsohn arrived to take charge. Ernst W. Bertner, M.D. was initial acting director, from 1942 to 1946.
In This Issue
- Staging the Aging: Geriatricians Help Older Patients Choose Cancer Treatment
- Resilient New Orleans Executive Tackles Colon Cancer Treatment
- Focus on Advanced Practice Nurses and Patient Care
- Data Powerhouse: MD Anderson's Tumor Registry
- Sex and the Female Cancer Patient
- Mendelsohn to Step Down, Change Role